IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy

Authors

  • U. Müller,

    Corresponding author
    • Division of Allergy, Department of Medicine, Spital Ziegler, Bern, Switzerland
    Search for more papers by this author
  • P. Schmid-Grendelmeier,

    1. Allergy Unit, Department of Dermatology, University Hospital of Zürich, Switzerland
    Search for more papers by this author
  • O. Hausmann,

    1. Division of Allergy, Department of Medicine, Spital Ziegler, Bern, Switzerland
    2. Division of Allergy, Department of Rheumatology, Clinical Immunology and Allergology, Inselspital, University of Bern, Switzerland
    Search for more papers by this author
  • A. Helbling

    1. Division of Allergy, Department of Medicine, Spital Ziegler, Bern, Switzerland
    2. Division of Allergy, Department of Rheumatology, Clinical Immunology and Allergology, Inselspital, University of Bern, Switzerland
    Search for more papers by this author

  • Edited by: Hans-Uwe Simon

Correspondence

Ulrich Müller, MD, Allergy Unit, Department of Medicine, Spital Ziegler, Spitalnetz Bern, Morillonstrasse 75, Bern CH-3007, Switzerland.

Tel.: 004131 970 7342

Fax: 004131 970 7537

E-mail: ulrich.mueller@spitalnetzbern.ch

Abstract

Background

Diagnostic tests in patients with Hymenoptera venom allergy are frequently positive to venoms of both honey bee and wasp (Vespula). Component-resolved analysis with recombinant species-specific major allergens (rSSMA) may help to distinguish true double sensitization from crossreactivity.

Methods

Included were 121 patients with systemic allergic reactions to Hymenoptera stings, 76 with double positivity of serum-specific IgE (sIgE) to both venoms, 45 with single positivity to bee or wasp venom, and 32 controls without history of systemic reactions to Hymenoptera stings and no sIgE to whole venoms. In venom-allergic patients and controls, sIgE to rSSMA Api m 1 of bee venom and to Ves v 1 and Ves v 5 of wasp venom were tested by ImmunoCAP.

Results

Only 47% of 76 patients with double positivity to whole venoms reacted also to rSSMA of both species. Specificity of sIgE to the 3 rSSMA was very high, with no sIgE to rSSMA of the other species in single-positive venom-allergic patients and only one control with low sIgE to Ves v 1. All wasp-allergic single-positive patients had sIgE to Ves v 5 and/or Ves v 1, and 78.3% of single-positive bee venom–allergic patients had sIgE to Api m 1.

Conclusion

Specificity of sIgE to rSSMA of both species is excellent. Sensitivity of sIgE to rSSMA was optimal for wasp venom. Sensitivity of bee venom Api m 1 could be increased by adding rSSMA of other important bee venom allergens.

Ancillary